δ(4)-3-氧代类固醇5β-还原酶缺乏症中SRD5B1（AKR1D1）基因分析：原发性基因缺陷的证据 - Suppr

Suppr

超能文献

SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect.

作者信息

Gonzales Emmanuel, Cresteil Danièle, Baussan Christiane, Dabadie Alain, Gerhardt Marie-Françoise, Jacquemin Emmanuel

出版信息

J Hepatol. 2004 Apr;40(4):716-8. doi: 10.1016/j.jhep.2003.12.024.

DOI:10.1016/j.jhep.2003.12.024

PMID:15030995

Abstract

摘要

相似文献

SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect.δ(4)-3-氧代类固醇5β-还原酶缺乏症中SRD5B1（AKR1D1）基因分析：原发性基因缺陷的证据

J Hepatol. 2004 Apr;40(4):716-8. doi: 10.1016/j.jhep.2003.12.024.

SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta4-steroid 5beta-reductase deficiency.原发性3-氧代-Δ4-类固醇5β-还原酶缺乏症的准确诊断需要进行SRD5B1基因分析。

J Gastroenterol Hepatol. 2009 May;24(5):776-85. doi: 10.1111/j.1440-1746.2008.05669.x. Epub 2008 Nov 3.

Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy.编码δ(4)-3-氧代类固醇5β-还原酶的基因SRD5B1（AKR1D1）突变与婴儿期肝炎和肝衰竭

Gut. 2003 Oct;52(10):1494-9. doi: 10.1136/gut.52.10.1494.

Distinguishing primary from secondary Δ(4) -3-oxosteroid 5β-reductase (SRD5B1, AKR1D1) deficiency by urinary steroid analysis.通过尿甾体分析鉴别原发性与继发性Δ(4)-3-氧代甾体5β-还原酶（SRD5B1，AKR1D1）缺乏症。

Clin Endocrinol (Oxf). 2015 Mar;82(3):346-51. doi: 10.1111/cen.12596. Epub 2014 Oct 27.

Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis.同卵双胞胎患新生儿肝炎时出现的δ4-3-氧代类固醇5β-还原酶缺乏症。胆汁酸合成中的一种新的先天性代谢缺陷。

J Clin Invest. 1988 Dec;82(6):2148-57. doi: 10.1172/JCI113837.

Primary ∆4-3-oxosteroid 5β-reductase deficiency: two cases in China.原发性 ∆4-3-氧代甾体 5β-还原酶缺乏症：中国两例报告。

World J Gastroenterol. 2012 Dec 21;18(47):7113-7. doi: 10.3748/wjg.v18.i47.7113.

AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases.AKR1D1 和 CYP7B1 基因突变与胆汁酸代谢先天性错误：可能被低估的疾病。

Pediatr Neonatol. 2020 Feb;61(1):75-83. doi: 10.1016/j.pedneo.2019.06.009. Epub 2019 Jul 4.

Gene analysis in delta 4-3-oxosteroid 5 beta-reductase deficiency.

Lancet. 1997 Feb 1;349(9048):329. doi: 10.1016/s0140-6736(05)62828-0.

Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy.口服胆酸治疗原发性胆汁酸合成遗传性缺陷：一种安全有效的长期疗法。

Gastroenterology. 2009 Oct;137(4):1310-1320.e1-3. doi: 10.1053/j.gastro.2009.07.043. Epub 2009 Jul 19.

[Delta 4-3-oxosteroid 5 beta-reductase deficiency].[δ4-3-氧代类固醇5β-还原酶缺乏症]

Ryoikibetsu Shokogun Shirizu. 1998(19 Pt 2):282-4.

引用本文的文献

5β-Dihydrosteroids: Formation and Properties.5β-二氢甾体：形成与性质。

Int J Mol Sci. 2024 Aug 14;25(16):8857. doi: 10.3390/ijms25168857.

Aldo-keto reductase (AKR) superfamily website and database: An update.醛酮还原酶（AKR）超家族网站和数据库：更新。

Chem Biol Interact. 2024 Aug 1;398:111111. doi: 10.1016/j.cbi.2024.111111. Epub 2024 Jun 13.

∆-3-oxo-5β-reductase deficiency: favorable outcome in 16 patients treated with cholic acid.∆-3-氧代-5β-还原酶缺乏症：16 例患者用胆酸治疗的良好结局。

Orphanet J Rare Dis. 2023 Dec 7;18(1):383. doi: 10.1186/s13023-023-02984-z.

Germline Mutations in Steroid Metabolizing Enzymes: A Focus on Steroid Transforming Aldo-Keto Reductases.类固醇代谢酶中的种系突变：重点关注类固醇转化醛酮还原酶。

Int J Mol Sci. 2023 Jan 18;24(3):1873. doi: 10.3390/ijms24031873.

Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma.醛酮还原酶（AKR）超家族基因在肝细胞癌中的调控网络及预后意义

J Hepatocell Carcinoma. 2021 Aug 30;8:997-1021. doi: 10.2147/JHC.S323743. eCollection 2021.

Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes.Δ4-3-氧代甾体 5β-还原酶缺乏症：口服胆汁酸治疗的反应和长期结果。

World J Gastroenterol. 2019 Feb 21;25(7):859-869. doi: 10.3748/wjg.v25.i7.859.

Loss of Enzymes in the Bile Acid Synthesis Pathway Explains Differences in Bile Composition among Mammals.胆汁酸合成途径中酶的缺失解释了哺乳动物之间胆汁组成的差异。

Genome Biol Evol. 2018 Dec 1;10(12):3211-3217. doi: 10.1093/gbe/evy243.

Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood.熊去氧胆酸治疗原发性胆汁酸合成缺陷：挽救生命的治疗方法，可使成年期获得良好结局。

Orphanet J Rare Dis. 2018 Oct 29;13(1):190. doi: 10.1186/s13023-018-0920-5.

Infant cholestasis patient with a novel missense mutation in the gene successfully treated by early adequate supplementation with chenodeoxycholic acid: A case report and review of the literature.婴儿胆汁淤积症患者在基因中存在新的错义突变，通过早期充分补充鹅去氧胆酸成功治疗：病例报告及文献复习。

World J Gastroenterol. 2018 Sep 21;24(35):4086-4092. doi: 10.3748/wjg.v24.i35.4086.

Structural and Functional Biology of Aldo-Keto Reductase Steroid-Transforming Enzymes.醛酮还原酶甾体转化酶的结构和功能生物学。

Endocr Rev. 2019 Apr 1;40(2):447-475. doi: 10.1210/er.2018-00089.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验